Studies were carried out to test the hypothesis that inflammatory liver disease increases the expression of specific cytochrome P-450 isoenzymes involved in aflatoxin B1 (AFB) activation. The immunohistochemical expression and localization of various human cytochrome P-450 isoforms, including CYP2A6, CYP1A2, CYP3A4, and CYP2B1, were examined in normal human liver and liver with hepatitis and cirrhosis. The constitutive expression of CYP3A4 in normal liver showed a characteristic pattern of distribution in centrilobular hepatocytes, whereas CYP1A2, CYP2A6, and CYP2B1 1 were expressed uniformly throughout the liver acinus. In sections of liver infected with hepatitis B virus (HBV) or hepatitis C virus (HCV), the expression of CYP2A6 was markedly increased in hepatocytes immediately adjacent to areas of fibrosis and inflammation. CYP3A4 and CYP2B 1 were induced to a lesser degree, and expression of CYP1A2 was unaffected. In HBV-infected liver, double immunostaining revealed that overexpression of CYP2A6 occurred in hepatocytes expressing the HBV core antigen. In HCV-infected liver, CYP2A6, CYP3A4, and CYP2B 1 were overexpressed in hepatocytes with hemosiderin pigmentation. These results suggest that alterations in phenotypic expression of specific P-450 isoenzymes in hepatocytes associated with hepatic inflammation and cirrhosis might increase susceptibility to AFB genotoxicity.
Antoniades HN (1992). Linking cellular injury to gene expression and human proliferative disorders: Examples with PDGF genes. Mol. Carcinogenesis6: 175-181.
2.
Aoyama T., Yamano S., Guzelian PS, Gelboin HV, and Gonzalez FJ (1990). Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B,. Proc. Natl. Acad. Sci. USA87: 4790-4793.
3.
Autrup H., Harris CC, Wu SM, Bao LY, Pei XF, Lu S., Sun TT, and Hsia CC (1984). Activation of chemical carcinogens by cultured human fetal liver, esophagus and stomach. Chem. Biol. Interact . 50: 15-25.
4.
Barker CW, Fagan JB, and Pasco CS (1992). Interleukin-1β suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J. Biol. Chem. 267: 8050-8055.
5.
Batt M. (1990). Arthritis and interleukin-1 stimulate P-450 IV . In: VIIth International Symposium on Microsomes and Drug Oxidations. Karolinska Institute, Sweden.
6.
Beaune P., Kremers F., Letawe-Goujon F., and Gielen JE (1985). Monoclonal antibodies against human liver cytochrome P-450. Biochem. Pharmacol. 34: 3547-3552.
7.
Bhat GJ and Padmanaban G. (1988). Heme is a positive regulator of cytochrome P-450 gene transcription. Arch. Biochem. Biophys. 264: 584-590.
8.
Bulatao-Jayme J., Almero EM, Castro MC, Jardeleza MT, and Salamat LA (1982). A case-control dietary study of primary liver cancer risk from aflatoxin exposure . Int. J. Epidemiol. 11: 112-119.
9.
Chisari FV, Filippi P., Buras J., McLachlan A., Popper H., Pinkert CA, Palmiter RD, and Brinster RL (1987). Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc. Natl. Acad. Sci. USA84: 6909-6913.
10.
Crespi CL, Penman BW, Leakey AE, Arlotto MP, Stark A., Parkinson A., Turner T., Steimel DT, Rudo K., Davies RL, and Langenbach R. (1990). Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis11: 1293-1300.
11.
Crespi CL, Penman BW, Steimel DT, Gelboin HV, and Gonzalez FJ (1991). The development of a human cell line stably expressing human CYP3A4: Role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis12: 355-359.
12.
Crespi CL, Steimel DT, Aoyama T., Gelboin HV, and Gonzalez FJ (1990). Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: Role of the enzyme in the metabolic activation of aflatoxin B1. Mol. Carcinogenesis3: 5-8.
13.
Fey GH and Gauldie J. (1990). Acute phase response of liver in inflammation . Prog. Liver Dis. 9: 89-116.
14.
Forrester LM , Henderson CJ, Glancey MJ, Back DJ, Park BK, Ball SE, Kitteringham NR, McLaren AW, Miles JS, Skett P., et al (1992). Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem. J. 281: 359-368.
15.
Forrester LM , Neal GE, Judah DJ, Glancey MJ, and Wolf CR (1990). Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B 1 metabolism in human liver. Proc. Natl. Acad. Sci. USA87: 8306-8310.
16.
Fritz P., Behrle E., Beaune P., Eichelbaum M., and Kroemer HK (1993). Differential expression of drug metabolizing enzymes in 3 primary and secondary liver neoplasm: Immunohistochemical characterization of cytochrome P4503A and glutathione S-transferase. Histochemistry99: 443-451.
17.
Fukuda Y., Ishida N., Noguchi T., Kappas A., and Sassa S. (1992). Interleukin-6 down regulates the expression of transcripts encoding cytochrome P450 1A1, 1A2, and IIIA3 in human hepatoma cells. Biochem. Biophys. Res. Comm. 184: 960-965.
18.
Gilmore JJL and Kirby GM (1996). Role of TGF-β and RNA-Binding Proteins in the Regulation of Human and Murine Hepatic Cytochrome P450 2A Class Isoenzymes . Presented at the ASBMB/ ASIP/AAI joint meeting , New Orleans.
19.
Guebel AP, Pauwels S., Buchet JP, Dumont E., and Dive C. (1987). Increased cyt P-450 dependent function in healthy HBsAg carriers. Pharmac. Ther. 33: 193-196.
20.
Harris CC (1994). Solving the viral-chemical puzzle of human liver carcinogenesis. Cancer Epidemiol. Biomark. Prev. 3: 1-2.
21.
Harris CC and Sun TT (1986). Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma. Cancer Surv. 5: 765-780.
22.
Kirby GM, Chemin I., Montesano R., Chisari FV, Lang MA, and Wild CP (1994). Induction of specific hepatic cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Mol. Carcinogenesis11: 74-80.
23.
Kirby GM, Pelkonen P., Vatanasapt V., Camus A.-M, Wild CP, and Lang MA (1994). Association of liver fluke (Opisthorchis viversini) infection with increased expression of cytochrome P450 and carcinogen metabolism in male hamster liver. Mol. Carcinogenesis11: 81-89.
24.
Kirby GM, Wolf CR, Neal GE, Judah DJ, Henderson CJ, Srivantanakul P., and Wild CP (1993). In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand. Carcinogenesis14: 2613-2620.
25.
Krzanowski JJ (1991). Cytochrome P450 isoforms: Regulation during infection, inflammation and by cytokines. J. Fla. Med. Assoc. 78: 517-519.
26.
Madra S. and Smith AG (1992). Induction of cytochrome P450 activities by polychlorinated biphenyls in isolated mouse hepatocytes. Influence of Ah-phenotype and iron. Biochem. Pharmacol. 44(3): 455-64.
27.
Montesano R. and Kirby GM (1994). Chemical carcinogens in human liver cancer. In: Primary Liver Cancer, C Brechot (ed). CRC Press, Boca Raton, Florida, pp. 57-77.
28.
Murray GI, Foster CO, Barnes TS, Weaver RJ, Snyder CP, Ewen SWB, Melvin WT, and Burke MD (1992). Cytochrome P450IA expression in adult and fetal human liver. Carcinogenesis13: 165-169.
29.
Neal GE, Metcalfe SA, Legg RF, Judah DJ, and Green JA (1981). Mechanism of the resistance to cytotoxicity which precedes aflatoxin B1 hepatocarcinogenesis. Carcinogenesis2: 457-461.
30.
Neal GE, Nielsch U., Judah DJ, and Hulbert PB (1987). Conjugation of model substrates or microsomally-activated aflatoxin B1 with reduced glutathione, catalysed by cytosolic glutathione S-transferases in livers of rats, mice and guinea pigs. Biochem. Pharm. 36: 4269-4276.
31.
Palmer CNA , Coates PJDavies SE, Shephard EA and Phillips IR (1992). Localization of cytochrome P-450 gene expression in normal and diseased human liver by in situ hybridization of wax-embedded archival material. Hepatology16: 682-687.
32.
Paulson KE, Darnell JE, Rushmore T., and Pickett CB (1990). Analysis of the upstream elements of the xenobiotic compound-inducible and positionally regulated glutathione S-transferase Ya gene. Mol. Cell. Biol. 10: 1841-1852.
33.
Peers F., Bosch X., Kaldor J., Linsell A., and Pluijmen M. (1987). Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int. J. Cancer39: 545-553.
34.
Prophet EB, Mills B, Arrington JB, and Sobin LH (eds) (1992). Laboratory Methods in Histotechnology . American Registry of Pathology, Washington, D.C.
35.
Qian G.-S., Ross RK, Yu MC, Yuan U.-M., Gao Y.-T., Henderson BE, Wogan GN, and Groopman JD (1994). A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomark. Prev. 3: 3-10.
36.
Quinn BA, Crane TL, Kocal TE, Best SJ, Cameron RG, Rushmore TH, Farber E., and Hayes MA (1990). Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1 . Toxicol. Appl. Pharmacol. 105: 351-363.
37.
Ramsdell JS , Parkinson A., Eddy AC, and Eaton DL (1991). Bioactivation of aflatoxin B1 by human liver microsomes: Role of cytochrome P450 IIIA enzymes. Toxicol. Appl. Pharmacol. 108: 436-447.
38.
Renton KW and Knickle LC (1989). Regulation of hepatic cytochrome P-450 during infectious disease. Can. J. Physiol. Pharmacol. 68: 777-781.
39.
Ross RK, Yuan J-M., Yu MC, Wogan GN, Qian G-S., Tu J-R., Groopman JD, Gao Y-T., and Henderson BE (1992). Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet339: 943-946.
40.
Smith AG, Carthew P., Francis JE, Cabral JR, and Manson MM (1993). Enhancement by iron of hepatic neoplasia in rats caused by hexachlorobenzene. Carcinogenesis14(7): 1381-1387.
41.
Trautwein C. , Ramadori G., Gerken G., Meyer zum Buschenfelde K-H., and Manns M. (1992). Regulation of cytochrome P450 IID by acute phase mediators in C3H/HeJ mice . Biochem. Biophys. Res. Comm. 182: 617-623.
42.
Twu J-S. and Schloemer RH (1987). Transcriptional trans-activating function of hepatitis B virus. J. Virol. 61: 3448-3453.
43.
Van Rensburg SJ, Cook-Mozaffari P., Van Schalkwyk DJ, Van der Watt J., Vincent TJ, and Purchase IF (1985). Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer51: 713-726.
44.
Wild CP, Fortuin M., Donato F., Whittle HC, Hall AJ, Wolf CR, and Montesano R. (1993). Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children. Cancer Epidemiol. Biomark. Prev. 2(6): 555-61.
45.
Yeh FS, Yu MC, Mo CC, Luo S., Tong MJ, and Henderson BE (1989). Hepatitis B virus, aflatoxins and hepatocelllar carcinoma in southern Guangxi, China. Cancer Res. 49: 2506-2509.
